SPINK7 and cancer: SPINK7 can bind to uPA with molecular weights of 55 and 33 kDa, reducing the proteolysis of the plasmin substrate d-v-ph-lys-p-nitroaniline and inhibiting the growth of cancer cells by downregulating uPA/plasmin activity (Figure 2) (180).